2026
article
OpenAlex
J Bousson, Christophe Van Steenkiste, Charlotte Gabriel, Vincent Bouderez et autres
This case discusses a 76-year-old female patient with a large mass at the major papilla of Vater, initially suspected to be an ampullary adenoma. The lesion, identified during an upper endoscopy for anemia and fatigue, showed chronic inflammation but no malignancy. The …
be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Leen JM. Heyens, Demi P.A.van Malde, Gediz Dogay Us, Francesco Innocenti et autres
INTRODUCTION AND OBJECTIVES: The screening accuracy of non-invasive fibrosis tests like FIB-4 in metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear. Using standard cut-offs, this study evaluated FIB-4's agreement with vibration-controlled transient elastography (VCTE) and identified and validated new thresholds. PATIENTS AND …
be, nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Leen Heyens, Francesco Innocenti, Christophe Van Steenkiste, Mathieu Struyve et autres
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely intertwined with glucose metabolism status (GMS). Bi-national comparative epidemiological data are lacking; therefore, this study aimed to provide new insights into MASLD and fibrosis prevalence and risk factors in Belgium, while comparing data …
nl, be
(code pays fourni par la source)
2025
article
OpenAlex
Arno Furquim d’Almeida, Axelle Vanderlinden, Stefan Bourgeois, Jean‐Pierre Mulkay et autres
BACKGROUND: Nucleos(t)ide analogue (NUC) cessation can induce a functional cure in chronic hepatitis B virus (HBV) infections, but severe post-cessation virologic relapses (SVRel) and severe biochemical flares (SBF) frequently occur. AIMS: To identify predictive biomarkers for patients at highest risk for SVRel …
be, fr, us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Lorenz Grossar, Sarah Raevens, Anja Geerts, Christophe Van Steenkiste et autres
2025
article
OpenAlex
Arno Furquim d’Almeida, Axelle Vanderlinden, Stefan Bourgeois, Jean‐Pierre Mulkay et autres
2025
conference-abstract
OpenAlex
Marie Coessens, Jolien de Graeve, Wim Verlinden, Anja Geerts et autres
2025
conference-abstract
OpenAlex
Leen Heyens, Christophe Van Steenkiste, Yves Kockaerts, Ine Lowyck et autres
Accès ouvert
2024
article
OpenAlex
Wouter Claeys, Anja Geerts, Lien Van Hoecke, Christophe Van Steenkiste et autres
Hepatic encephalopathy, defined as neuropsychiatric dysfunction secondary to liver disease, is a frequent decompensating event in cirrhosis. Its clinical impact is highlighted by a notable increase in patient mortality rates and a concomitant reduction in overall quality of life. Systemically, liver disease, …
be
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Emily Taillieu, Christophe Van Steenkiste, Koen Chiers, Freddy Haesebrouck
Sinds enkele decennia is bekend dat de maag geen steriele omgeving is. In de diergeneeskunde zijn er tal van niet-Helicobacter pylori Helicobacter (NHPH) species die de maag van onder andere katten, honden en varkens koloniseren. Binnen de humane geneeskunde werd tot voor …
Accès ouvert
2024
article
OpenAlex
Cédric Peleman, Stig Hellemans, Geraldine Veeckmans, Wout Arras et autres
There is an unmet clinical need for pharmacologic treatment for metabolic dysfunction-associated steatotic liver disease (MASLD). Hepatocyte cell death is a hallmark of this highly prevalent chronic liver disease, but the dominant type of cell death remains uncertain. Here we report that …
be, jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Lorenz Grossar, Sarah Raevens, Christophe Van Steenkiste, Isabelle Colle et autres
Background & Aims: The goal of treatment in autoimmune hepatitis (AIH) is induction of remission to prevent the development of liver fibrosis, cirrhosis, and its related complications. Various definitions of treatment response and remission have been used. The International Autoimmune Hepatitis Group …
be
(code pays fourni par la source)